Novavax, Inc. (NVAX) Reports Q3 Loss of $0.03
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
